Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
M01AC Oxicams
M01AC06 Meloxicam
D00969 Meloxicam (JAN/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Analgesics
Nonsteroidal Anti-inflammatory Drugs
Meloxicam
D00969 Meloxicam (JAN/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
114 Antipyretics and analgesics, anti-inflammatory agents
1149 Others
D00969 Meloxicam (JAN/USP/INN)
Animal drugs in Japan [BR:br08331]
91 Agents affecting nervous system
913 Antipyretics, analgesics and antiinflammatory
9139 Other antipyretics, analgesics and antiinflammatory
C08169 Meloxicam
Drug groups [BR:br08330]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01910 Anti-inflammatory drug, oxicams
D00969 Meloxicam
DG01922 Selective COX2 inhibitor
D00969 Meloxicam
Metabolizing enzyme substrate
DG01642 CYP2C9 substrate
D00969 Meloxicam
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D00969 Meloxicam
Drug classes [BR:br08332]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
D00969 Meloxicam
D00969 Meloxicam
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Prostaglandin synthase
PTGS2 (COX2)
D00969 Meloxicam (JAN/USP/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D00969
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D00969
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D00969
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D00969